Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation

Manuela Capozza, Iolanda Chinellato, Vito Guarnieri, Natascia Di Iorgi, Maria Accadia, Cristina Traggiai, Girolamo Mattioli, Antonio Di Mauro, Nicola Laforgia

Research output: Contribution to journalArticle

Abstract

BackgroundNeonatal severe primary hyperparathyroidism (NSHPT) is a rare autosomal recessive disorder of calcium homeostasis, characterized by striking hyperparathyroidism, marked hypercalcemia and hyperparathyroid bone disease. We report the case of a newborn with a novel homozygous mutation of the CaSR, treated by successful subtotal parathyroidectomy, who had an acute presentation of the disease, i.e. out-of hospital cardiorespiratory arrest. .Case presentationA 8-day-old female newborn was admitted to the NICU of University of Bari Aldo Moro (Italy) after a cardiorespiratory arrest occurred at home. Severe hypercalcemia was found and different drug therapies were employed (Furosemide, Cinacalcet and bisphosphonate), as well as hyperhydration, until subtotal parathyroidectomy, was performed at day 32. Our patient's mutation was never described before so that a strict and individualized long-term follow-up was started.ConclusionsThis case of NSHPT suggests that a near-miss event, labelled as a possible case of SIDS, could also be due to severe hypercalcemia and evidentiates the difficulties of the neonatal management of NSHPT. Furthermore, the identification of the specific CaSR mutation provides the substrate for prenatal diagnosis.
Original languageEnglish
JournalBMC Pediatrics
Volume18
DOIs
Publication statusPublished - Oct 30 2018

Fingerprint

Primary Hyperparathyroidism
Hypercalcemia
Parathyroidectomy
Mutation
Newborn Infant
Sudden Infant Death
Hyperparathyroidism
Bone Diseases
Furosemide
Diphosphonates
Acute Disease
Prenatal Diagnosis
Italy
Homeostasis
Calcium
Drug Therapy

Keywords

  • Hypercalcemia
  • Calcium sensing receptor
  • Neonatal severe primary hyperparathyroidism
  • Out-of-hospital cardiorespiratory arrest
  • Parathyroidectomy

Cite this

Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. / Capozza, Manuela; Chinellato, Iolanda; Guarnieri, Vito; Di Iorgi, Natascia; Accadia, Maria; Traggiai, Cristina; Mattioli, Girolamo; Di Mauro, Antonio; Laforgia, Nicola.

In: BMC Pediatrics, Vol. 18, 30.10.2018.

Research output: Contribution to journalArticle

@article{a16e6bb3a04a4e1dbc02f9bcfc642df4,
title = "Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation",
abstract = "BackgroundNeonatal severe primary hyperparathyroidism (NSHPT) is a rare autosomal recessive disorder of calcium homeostasis, characterized by striking hyperparathyroidism, marked hypercalcemia and hyperparathyroid bone disease. We report the case of a newborn with a novel homozygous mutation of the CaSR, treated by successful subtotal parathyroidectomy, who had an acute presentation of the disease, i.e. out-of hospital cardiorespiratory arrest. .Case presentationA 8-day-old female newborn was admitted to the NICU of University of Bari Aldo Moro (Italy) after a cardiorespiratory arrest occurred at home. Severe hypercalcemia was found and different drug therapies were employed (Furosemide, Cinacalcet and bisphosphonate), as well as hyperhydration, until subtotal parathyroidectomy, was performed at day 32. Our patient's mutation was never described before so that a strict and individualized long-term follow-up was started.ConclusionsThis case of NSHPT suggests that a near-miss event, labelled as a possible case of SIDS, could also be due to severe hypercalcemia and evidentiates the difficulties of the neonatal management of NSHPT. Furthermore, the identification of the specific CaSR mutation provides the substrate for prenatal diagnosis.",
keywords = "Hypercalcemia, Calcium sensing receptor, Neonatal severe primary hyperparathyroidism, Out-of-hospital cardiorespiratory arrest, Parathyroidectomy",
author = "Manuela Capozza and Iolanda Chinellato and Vito Guarnieri and {Di Iorgi}, Natascia and Maria Accadia and Cristina Traggiai and Girolamo Mattioli and {Di Mauro}, Antonio and Nicola Laforgia",
year = "2018",
month = "10",
day = "30",
doi = "10.1186/s12887-018-1319-0",
language = "English",
volume = "18",
journal = "BMC Pediatrics",
issn = "1471-2431",
publisher = "BMC",

}

TY - JOUR

T1 - Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation

AU - Capozza, Manuela

AU - Chinellato, Iolanda

AU - Guarnieri, Vito

AU - Di Iorgi, Natascia

AU - Accadia, Maria

AU - Traggiai, Cristina

AU - Mattioli, Girolamo

AU - Di Mauro, Antonio

AU - Laforgia, Nicola

PY - 2018/10/30

Y1 - 2018/10/30

N2 - BackgroundNeonatal severe primary hyperparathyroidism (NSHPT) is a rare autosomal recessive disorder of calcium homeostasis, characterized by striking hyperparathyroidism, marked hypercalcemia and hyperparathyroid bone disease. We report the case of a newborn with a novel homozygous mutation of the CaSR, treated by successful subtotal parathyroidectomy, who had an acute presentation of the disease, i.e. out-of hospital cardiorespiratory arrest. .Case presentationA 8-day-old female newborn was admitted to the NICU of University of Bari Aldo Moro (Italy) after a cardiorespiratory arrest occurred at home. Severe hypercalcemia was found and different drug therapies were employed (Furosemide, Cinacalcet and bisphosphonate), as well as hyperhydration, until subtotal parathyroidectomy, was performed at day 32. Our patient's mutation was never described before so that a strict and individualized long-term follow-up was started.ConclusionsThis case of NSHPT suggests that a near-miss event, labelled as a possible case of SIDS, could also be due to severe hypercalcemia and evidentiates the difficulties of the neonatal management of NSHPT. Furthermore, the identification of the specific CaSR mutation provides the substrate for prenatal diagnosis.

AB - BackgroundNeonatal severe primary hyperparathyroidism (NSHPT) is a rare autosomal recessive disorder of calcium homeostasis, characterized by striking hyperparathyroidism, marked hypercalcemia and hyperparathyroid bone disease. We report the case of a newborn with a novel homozygous mutation of the CaSR, treated by successful subtotal parathyroidectomy, who had an acute presentation of the disease, i.e. out-of hospital cardiorespiratory arrest. .Case presentationA 8-day-old female newborn was admitted to the NICU of University of Bari Aldo Moro (Italy) after a cardiorespiratory arrest occurred at home. Severe hypercalcemia was found and different drug therapies were employed (Furosemide, Cinacalcet and bisphosphonate), as well as hyperhydration, until subtotal parathyroidectomy, was performed at day 32. Our patient's mutation was never described before so that a strict and individualized long-term follow-up was started.ConclusionsThis case of NSHPT suggests that a near-miss event, labelled as a possible case of SIDS, could also be due to severe hypercalcemia and evidentiates the difficulties of the neonatal management of NSHPT. Furthermore, the identification of the specific CaSR mutation provides the substrate for prenatal diagnosis.

KW - Hypercalcemia

KW - Calcium sensing receptor

KW - Neonatal severe primary hyperparathyroidism

KW - Out-of-hospital cardiorespiratory arrest

KW - Parathyroidectomy

U2 - 10.1186/s12887-018-1319-0

DO - 10.1186/s12887-018-1319-0

M3 - Article

VL - 18

JO - BMC Pediatrics

JF - BMC Pediatrics

SN - 1471-2431

ER -